Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376

Ionic dependence of glutamate neurotoxicity

Choi, D. W. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,854

Localization of neuronal and glial glutamate transporters

Rothstein, J. D., Martin, L. J., Levey, A. I., Dykes‐Hoberg, M., Jin, L., Wu, D. M., Nash, N. R., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,703

Molecular Mechanisms of Synaptic Disconnection in Alzheimer’s Disease

Masliah, E., Mallory, M. E., Alford, M. F., DeTeresa, R. M., Iwai, A., & Saitoh, T. (1997) · Springer eBooks · doi:10.1007/978-3-642-60680-9_9 · Cited by 19

Altered expression of glutamate transporters under hypoxic conditions in vitro

Hsu, L. J., Rockenstein, E. M., Mallory, M. E., Hashimoto, M., & Masliah, E. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1065 · Cited by 19

CEST imaging combined with 1H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer’s disease mice

Shen, Y., Zhang, X., Liu, S.-Q., Xin, L., Xuan, W., Zhuang, C., Chen, Y., Chen, B., Zheng, X., Wu, R., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01672-3 · Cited by 18

Astrocyte-Synapse Structural Plasticity in Neurodegenerative and Neuropsychiatric Diseases

Badia‐Soteras, A., Mak, A., Blok, T. M., Boers-Escuder, C., van den Oever, M. C., Min, R., Smit, A. B., & Verheijen, M. H. G. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.04.011 · Cited by 21

Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders

Dogra, S., Putnam, J., & Conn, P. J. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173493 · Cited by 17

Asymmetric dysregulation of glutamate dynamics across the synaptic cleft in a mouse model of Alzheimer’s disease

Brymer, K. J., Hurley, E. P., Barron, J. C., Mukherjee, B., Barnes, J. R., Nafar, F., & Parsons, M. P. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01524-x · Cited by 18

Sleep/Wake Behavior and EEG Signatures of the TgF344-AD Rat Model at the Prodromal Stage

Kreuzer, M., Keating, G. L., Fenzl, T., Härtner, L., Sinon, C. G., Hajjar, I. M., Ciavatta, V. T., Rye, D. B., & García, P. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239290 · Cited by 17

Entering a new era of quantifying glutamate clearance in health and disease

Brymer, K. J., Barnes, J. R., & Parsons, M. P. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24810 · Cited by 17

Hippocampal Synaptic Dysfunction in a Mouse Model of Huntington Disease Is Not Alleviated by Ceftriaxone Treatment

Wilkie, C. M., Barnes, J. R., Benson, C.-L. M., Brymer, K. J., Nafar, F., & Parsons, M. P. (2020) · eNeuro · doi:10.1523/eneuro.0440-19.2020 · Cited by 17

Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice

Tomasini, M. C., Borelli, A. C., Beggiato, S., Ferraro, L., Cassano, T., Tanganelli, S., & Antonelli, T. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143039 · Cited by 17

Glutamato y enfermedad de Alzheimer

Abío, J. G., & Cavero-Nagore, M. (2006) · Revista de Neurología · doi:10.33588/rn.4207.2005223 · Cited by 17

Glyoxal inactivates glutamate transporter‐1 in cultured rat astrocytes

Kawaguchi, M., Shibata, N., Horiuchi, S., & Kobayashi, M. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2004.00579.x · Cited by 17

Exendin (5-39), an antagonist of GLP-1 receptor, modulates synaptic transmission via glutamate uptake in the dentate gyrus

Kobayashi, K., Iwai, T., Sasaki‐Hamada, S., Kamanaka, G., & Oka, J. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.012 · Cited by 17

Differential effects of inhibitors of PTZ‐induced kindling on glutamate transporters and enzyme expression

Taşpınar, N., Hacımüftüoğlu, A., Butuner, S., Toğar, B., Arslan, G., Taghizadehghalehjoughi, A., Okkay, U., Ağar, E., Stephens, R., Türkez, H., et al. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13575 · Cited by 16

Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease

Saavedra, J., Nascimento, M., Liz, M. A., & Cardoso, I. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036123 · Cited by 16

Space-Dependent Glia–Neuron Interplay in the Hippocampus of Transgenic Models of β-Amyloid Deposition

Lana, D., Ugolini, F., & Giovannini, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249441 · Cited by 17

Association Analysis for the Genetic Variants of the NMDA Receptor Subunit 2b and Alzheimer’s Disease

Tsai, S., Liu, H.-C., Liu, T., Cheng, C., & Hong, C. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000048639 · Cited by 16

Excitatory amino acid transporters as emerging targets for central nervous system therapeutics

Dunlop, J., Zaleska, M. M., Eliasof, S. D., & Moyer, J. A. (1999) · Emerging Therapeutic Targets · doi:10.1517/14728222.3.4.543 · Cited by 16

Acute manganese exposure impairs glutamatergic function in a young mouse model of Alzheimer’s disease

Spitznagel, B. D., Buchanan, R. A., Consoli, D. C., Thibert, M., Bowman, A. B., Nobis, W. P., & Harrison, F. E. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.01.002 · Cited by 15

Glutamate Receptors in Aging and Alzheimer's Disease

Mishizen-Eberz, A. J., Ikonomović, M. D., & Armstrong, D. M. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50022-6 · Cited by 18

Quantitative autoradiography of Na+-dependent [3H]l-aspartate binding to l-glutamate transporters in rat brain: structure-activity studies using l-trans-pyrrolidine-2,4-dicarboxylate (l-t-PDC) and 2-(carboxycyclopropyl)-glycine (CCG)

Lieb, I., Chebib, M., Cooper, B., Dias, L. S., & Balcar, V. J. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00140-0 · Cited by 15

Magnetic Resonance Spectroscopic Methods for the Assessment of Metabolic Functions in the Diseased Brain

Hall, H., Cuellar-Baena, S., Dahlberg, C., in’t Zandt, R., Denisov, V., & Kirik, D. (2011) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2011_166 · Cited by 17

Serine Racemase Expression Differentiates Aging from Alzheimer’s Brain

Wu, S., Zhou, J., Zhang, H., & Barger, S. W. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220805105106 · Cited by 14

Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies

Moussa, C., Rusnak, M., Hailu, A., Sidhu, A., & Fricke, S. T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.09.023 · Cited by 14

Potential neuroprotective effects of cinnamon

Stavinoha, R., & Vattem, D. A. (2015) · International journal of applied research in natural products · Cited by 14

Moschus ameliorates glutamate-induced cellular damage by regulating autophagy and apoptosis pathway

Xie, D., Song, C., Qin, T., Zhai, Z., Cai, J., Dai, J., Sun, T., & Xu, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-45878-7 · Cited by 13

Sulbactam protects neurons against double neurotoxicity of amyloid beta and glutamate load by upregulating glial glutamate transporter 1

Li, L., Li, W., Jiang, W., & Xu, R. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01827-5 · Cited by 13

Key network approach reveals new insight into Alzheimer's disease

Schluesener, J. K., Zhu, X., Schluesener, H. J., Wang, G., & Ao, P. (2014) · IET Systems Biology · doi:10.1049/iet-syb.2013.0047 · Cited by 13

SUN11602 has basic fibroblast growth factor-like activity and attenuates neuronal damage and cognitive deficits in a rat model of Alzheimer׳s disease induced by amyloid β and excitatory amino acids

Ogino, R., Murayama, N., Noshita, T., Takemoto, N., Toba, T., Oka, T., Narii, N., Yoshida, S., Ueno, N., & Inoue, T. (2014) · Brain Research · doi:10.1016/j.brainres.2014.08.023 · Cited by 13

Cellular Protection and Therapeutic Potential of Tocotrienols

Catalgol, B., Batırel, S., & Özer, N. K. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796957436 · Cited by 12

Positive allosteric activation of glial EAAT-2 transporter protein: A novel strategy for Alzheimer’s disease

Manisha, C., Ayyamperumal, S., Selvaraj, J., Nanjan, C. M. J., Joghee, N. M., Clement, J. P., & Justin, A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109794 · Cited by 13

Neurochemistry of L-Glutamate Transport in the CNS: A Review of Thirty Years of Progress

Balcar, V. J., Takamoto, A. H. R., & Yoneda, Y. (2001) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc20011315 · Cited by 13

Redox Proteomics: A New Approach to Investigate Oxidative Stress in Alzheimer's Disease

Butterfield, D. A., Rukhsana Sultana, A., & Poon, H. F. (2006) · Wiley eBooks · doi:10.1002/0471973122.ch18 · Cited by 13

Increased excitatory amino acid transport into murine prion protein knockout astrocytes cultured in vitro

Pathmajeyan, M. S., Patel, S. A., Carroll, J. A., Seib, T., Striebel, J. F., Bridges, R. J., & Chesebro, B. W. (2011) · Glia · doi:10.1002/glia.21215 · Cited by 12

4-Hydroxyhexenal (HHE) Impairs Glutamate Transport in Astrocyte Cultures

Lovell, M. A., Bradley‐Whitman, M. A., & Fister, S. X. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120409 · Cited by 15

LY379268 Does Not Have Long-Term Procognitive Effects nor Attenuate Glutamatergic Signaling in AβPP/PS1 Mice

Hascup, K. N., Britz, J., Findley, C. A., Tischkau, S. A., & Hascup, E. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181231 · Cited by 13

The consequences of neurodegenerative disease on neuron-astrocyte metabolic and redox interactions

Jiwaji, Z., & Hardingham, G. E. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106255 · Cited by 11

Impaired astrocytic synaptic function by peripheral cholesterol metabolite 27-hydroxycholesterol

Spanos, F., Gerenu, G., Goikolea, J., Latorre-Leal, M., Balleza-Tapia, H., Gomez, K., Álvarez-Jiménez, L., Piras, A., Gómez-Galán, M., Fisahn, A., et al. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1347535 · Cited by 10

Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting

Sandoval, K. E., & WITT, K. A. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001117 · Cited by 14

S1P2-Gα12Signaling Controls Astrocytic Glutamate Uptake and Mitochondrial Oxygen Consumption

Jonnalagadda, D., Kihara, Y., Rivera, R. R., & Chun, J. J. M. (2021) · eNeuro · doi:10.1523/eneuro.0040-21.2021 · Cited by 11

Low micromolar Ba2+ potentiates glutamate transporter current in hippocampal astrocytes

Afzalov, R. A., Pryazhnikov, E., Shih, P., Kondratskaya, E., Николаевна, З. С., Leino, S., Salminen, O., Khiroug, L. S., & Semyanov, A. V. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00135 · Cited by 11

The Mammalian Transporter Families

Landowski, C. P., Suzuki, Y., & Hediger, M. A. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50007-3 · Cited by 12

Common and divergent pathways in early stages of glutamate and tau-mediated toxicities in neurodegeneration

Chongtham, A., Sharma, A., Nath, B., Murtha, K., Gorbachev, K., Ramakrishnan, A., Schmidt, E. F., Shen, L., & Pereira, A. C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114967 · Cited by 10

Are Hippocampal Hypoperfusion and ATP Depletion Prime Movers in the Genesis of Alzheimer’s Disease? A Review of Recent Pertinent Observations from Molecular Biology

Walker, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157328 · Cited by 11

The accessible cerebral vascular proteome in a mouse model of cerebral β-amyloidosis

Roesli, C., Fugmann, T., Borgia, B., Schliemann, C., Neri, D., & Jucker, M. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.01.010 · Cited by 10

Altered synaptic glutamate homeostasis contributes to cognitive decline in young APP/PSEN1 mice

Wilcox, J. M., Consoli, D. C., Tienda, A. A., Dixit, S., Buchanan, R. A., May, J. M., Nobis, W. P., & Harrison, F. E. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105486 · Cited by 10

Specialized Neurotransmitter Transporters in Astrocytes

Yang, Y., & Rothstein, J. D. (2008) · Springer eBooks · doi:10.1007/978-0-387-79492-1_4 · Cited by 9

Paroxetine prevented the down-regulation of astrocytic L-Glu transporters in neuroinflammation

Fujimori, K., Takaki, J., Shigemoto‐Mogami, Y., Sekino, Y., Suzuki, T., & Sato, K. (2014) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2014.09.002 · Cited by 10

Antiglutamate therapy of ALS — which is the next step?

Ludolph, A. C., Meyer, T., & Riepe, M. W. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6369-6_8 · Cited by 10

Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets

Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12

The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential

Abedin, M. J., & Kastanenka, K. V. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251411561 · Cited by 9

Fast Interneuron Dysfunction in Laminar Neural Mass Model Reproduces Alzheimer's Oscillatory Biomarkers

Sanchez-Todo, R., Mercadal, B., Lopez-Sola, E., Guasch-Morgades, M., Deco, G., & Ruffini, G. (2026) · Human Brain Mapping · doi:10.1002/hbm.70428 · Cited by 9

Variations of Glutamate Concentration Within Synaptic Cleft in the Presence of Electromagnetic Fields: An Artificial Neural Networks Study

Masoudian, N., Riazi, G. H., Afrasiabi, A., Modaresi, S. M. S., Dadras, A., Rafiei, S., Yazdankhah, M., Liaghi, A., Jarah, M., Ahmadian, S., et al. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1509-6 · Cited by 9

Atorvastatin and Aβ(1–40): Not as Simple as Cholesterol Reduction in Brain and Relevance to Alzheimer Disease

Butterfield, D. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.014 · Cited by 9

The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer’s Disease

de Lima, I. B. Q., & Ribeiro, F. M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x20666211223140303 · Cited by 9

Design and Characterization of Novel Small Molecule Activators of Excitatory Amino Acid Transporter 2

Das, S., Trubnikov, A. V., Novoselov, A. M., Kurkin, A. V., Beld, J., Altieri, A., & Kortagere, S. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00304 · Cited by 9

Conformational free energy landscape of a glutamate transporter and microscopic details of its transport mechanism

Thangapandian, S., Fakharzadeh, A., Moradi, M., & Tajkhorshid, E. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2416381122 · Cited by 8

Rescue of synaptosomal glutamate release defects in tau transgenic mice by the tau aggregation inhibitor hydromethylthionine

Cranston, A., Kraev, I., Stewart, M. G., Horsley, D., Santos, R. X., Robinson, L., Dreesen, E., Armstrong, P., Palliyil, S., Harrington, C. R., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111269 · Cited by 7

NDRG2 Expression Correlates with Neurofibrillary Tangles and Microglial Pathology in the Ageing Brain

Fadul, M. M., Garwood, C. J., Waller, R., Garrett, N., Heath, P. R., Matthews, F. E., Brayne, C., Wharton, S. B., & Simpson, J. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21010340 · Cited by 9

Complex Processes Underlying the Dynamic Changes of D-serine Levels in AD Brains

Ni, X., & Mori, H. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220328123048 · Cited by 8

Ibuprofen treatment ameliorates memory deficits in rats with collagen-induced arthritis by normalizing aberrant MAPK/NF-κB and glutamatergic pathways

Zhang, N.-Y., Wang, T., Chou, C.-H., Wu, K.-C., Yang, C., Kung, F., & Lin, C. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175256 · Cited by 8

Acoustic Stress Induces Opposite Proliferative/Transformative Effects in Hippocampal Glia

Cruz-Mendoza, F., Luquı́n, S., Garcı́a‐Estrada, J., Fernández-Quezada, D., & Jáuregui-Huerta, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065520 · Cited by 7

The Pro-Apoptotic Substance Thapsigargin Selectively Stimulates Re-Growth of Brain Capillaries

Ullrich, C., & Humpel, C. (2009) · Current Neurovascular Research · doi:10.2174/156720209788970063 · Cited by 8

The Leukocentric Theory of Neurological Disorder: A Manifesto

Fern, R. F. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2279-8 · Cited by 8

Proteases and Alzheimer’s Disease: Present Knowledge and Emerging Concepts of Therapy

Bernstein, H. (2006) · Springer eBooks · doi:10.1007/0-387-23101-3_1 · Cited by 8

NEUROTOXIC MECHANISMS OF DEGENERATION IN MOTOR NEURON DISEASES*

Ludolph, A. C., & Münch, C. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101938 · Cited by 8

Neurotransmitter Systems in Alzheimer’s Disease

Ramı́rez-Expósito, M. J., Cueto‐Ureña, C., & Martı́nez-Martos, J. M. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48030334 · Cited by 7

Glutamate Transporter Dysfunction and Neuronal Death

Ganel, R., & Rothstein, J. D. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-08022-1_15 · Cited by 7

Expression and phosphorylation of δ-CaM kinase II in cultured Alzheimer fibroblasts

Cavazzin, C., Bonvicini, C., Nocera, A., Racchi, M., Kasahara, J., Tardito, D., Gennarelli, M., Govoni, S. M., Racagni, G., & Popoli, M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.003 · Cited by 7

A major role for astrocytes in the neuroprotective effect of estrogen

Sortino, M. A., Platania, P., Chisari, M., Merlo, S., Copani, A., & Catania, M. V. (2005) · Drug Development Research · doi:10.1002/ddr.20051 · Cited by 6

Deciphering the Structural Biology of GFAP: Connotations of Its Potency in Presaging the Diagnosis for Traumatic Brain Injury and AD

Kanuri, S. H., & Sirrkay, P. J. (2025) · Neurology International · doi:10.3390/neurolint17090134 · Cited by 7

Observing spontaneous, accelerated substrate binding in molecular dynamics simulations of glutamate transporters

Wang, J., Li, P.-F., Yu, X., & Grewer, C. T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250635 · Cited by 6

Genetically-encoded halide sensor-based fluorescent assay for rapid screening of glutamate transport and inhibition.

Zielewicz, L., & Grewer, C. (2019) · ACS Sensors · doi:10.1021/acssensors.9b00944 · Cited by 6

In vitro CNS tissue analogues formed by self‐organisation of reaggregated post‐natal brain tissue

Bailey, J. L., O'Connor, V. M., Hannah, M. J., Hewlett, L. J., Biggs, T. E., Sundström, L., Findlay, M., & Chad, J. E. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07276.x · Cited by 6

Benzodiazepines differently modulate EAAT1/GLAST and EAAT2/GLT1 glutamate transporters expressed in CHO cells

Palmada, M., Kinne-Saffran, E., Centelles, J. J., & Kinne, R. K.-H. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00087-0 · Cited by 6

Reactive Astrocytes with Reduced Function of Glutamate Transporters in the App NL-G-F Knock-in Mice

Srivastava, I., Goikolea, J., Kaya, T. A., Latorre‐Leal, M., Eroli, F., Iglesias, M. P., Álvarez-Jiménez, L., Arroyo‐García, L. E., Shimozawa, M., Nilsson, P., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00714 · Cited by 8

The NMDAR/TRPM4 death complex is a major promoter of disease progression in the 5xFAD mouse model of Alzheimer’s disease

Yan, J., Yang, X., Li, G., Ramírez, O. A., Hagenston, A. M., Chen, Z.-Y., & Bading, H. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03143-5 · Cited by 6

NETosis in Alzheimer’s Disease: Understanding the Role of Neutrophil Extracellular Traps (NETs) in Neuroinflammation and Disease Pathogenesis

Rao, R., Verma, H., Gangwar, P., Yadav, A., Yadav, B., Patel, A., Kaur, S., Dhiman, M., & Mantha, A. K. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05435-x · Cited by 5

Ascorbate insufficiency disrupts glutamatergic signaling and alters electroencephalogram phenotypes in a mouse model of Alzheimer's disease

Buchanan, R. A., Wang, Y., May, J. M., & Harrison, F. E. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106602 · Cited by 5

Genome scan in familial late‐onset Alzheimer's disease: A locus on chromosome 6 contributes to age‐at‐onset

Zhao, W., Blue, E., Cheung, C. Y. K., Steinbart, E. J., Schellenberg, G. D., Bird, T. D., & Wijsman, E. M. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32133 · Cited by 5

Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis

Gironi, M., Costa, G. D., Frigo, M., Rovaris, M., Clerici, M., Bazzini, C., Andreoni, S., Comı, G., Furlan, R., Ferrarese, C., et al. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102007 · Cited by 5

Design and Characterization of Prodrug-like Inhibitors for Preventing Glutamate Efflux through Reverse Transport

Zielewicz, L. J., Wang, J., Ndaru, E., Maney, B., Yu, X., Albers, T., & Grewer, C. T. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00651 · Cited by 5

Neuropathological Correlates of Dementia in Alzheimer’s Disease

Masliah, E., & Salmon, D. P. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_15 · Cited by 5

Loss of Age-Associated Increase in m6A-Modified RNA Contributes to GABAergic Dysregulation in Alzheimer's DiseasePreprint

Libera, J., Hu, J., Hu, J., Nguyen, T.-A., Wang, Z., van der Spek, S. J. F., Schult, K., Dorrian, L., Majka, J., Tobunluepop, K., et al. (2025) · SSRN Electronic Journal · doi:10.1101/2025.05.02.651974 · Cited by 7

ABCA7 deficiency exacerbates glutamate excitotoxicity in Alzheimer’s disease mice – A new pharmacological target for Glu-related neurotoxicity

Górska, A. M., Santos‐García, I., Kvasnička, A., Dobešová, D., Friedecký, D., Gildenblat, J., & Pahnke, J. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102891 · Cited by 6

PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease

Perrin, F., Anderson, L. C., Mitchell, S. P. C., Sinha, P., Turchyna, Y., Maesako, M., Houser, M. C., Zhang, C. M., Wagner, S. L., Tanzi, R. E., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01876-y · Cited by 6

Amyloid β-Peptide(1-42), Oxidative Stress, and Alzheimer’s Disease

Butterfield, D. A. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_5 · Cited by 4

Emerging Roles for Glial Pathology in Addiction

Reissner, K. J., & Kalivas, P. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_17 · Cited by 4

The Glutamatergic System in Alzheimer’s Disease Brain: Dysfunction Associated with Amyloid β-Peptide and Oxidative Stress

Butterfield, D. A. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8959-8_14 · Cited by 3

Glutamate Transporter 1 as a Novel Negative Regulator of Amyloid β

Sinha, P., Turchyna, Y., Mitchell, S., Sadek, M., Armagan, G., Perrin, F., Maesako, M., & Berezovska, O. (2024) · Cells · doi:10.3390/cells13191600 · Cited by 3

Free fatty acids inhibit an ion-coupled membrane transporter by dissipating the ion gradient

Wang, X., Rusinova, R., Gregorio, G. G., & Boudker, O. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107955 · Cited by 3

Loliolide combats glutamate-induced neurotoxicity by oxidative stress through MAPK/Nrf2 pathway in hippocampal neuronal cells

Kim, H., Cheon, J., Kirindage, K. G. I. S., Jayasinghe, A. M. K., Han, E. J., Park, S.-M., Ahn, G., & Cha, S. (2024) · Algal Research · doi:10.1016/j.algal.2024.103866 · Cited by 3

The relationship between neurotransmission-related amino acid blood concentrations and neuropsychological performance following acute exercise

Parthimos, T. P., Schulpis, K. H., Karousi, A. D., Loukas, Y. L., & Dotsikas, Y. (2022) · Applied Neuropsychology Adult · doi:10.1080/23279095.2022.2043327 · Cited by 3

The contribution of S100B to the glioprotective effects of valproic and arundic acids.

Keshavarz, M., Farrokhi, M. R., Amiri, A., & Hosseini, M. (2019) · PubMed Central · doi:10.22038/ijbms.2019.29852.7204 · Cited by 3

Glutamate Receptors and Neurological Disorders

Farooqui, A. A., Ong, W., & Horrocks, L. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-73023-3_8 · Cited by 3

Cellular Signaling Pathways in Neuronal Apoptosis

Cotman, C. W., Qian, H., & Anderson, A. J. (2000) · doi:10.1007/978-1-59259-019-3_7 · Cited by 3

[Cellular and molecular mechanisms of neurodegeneration].

Pasantes‐Morales, H., Massieu, L., Arias, C., & Tapia, R. (1998) · PubMed · Cited by 3

Differential impact of manganese on glutamate clearance, electroencephalography, and sleep in Alzheimer's disease

Buchanan, R. A., Kramer, A. T., Calipari, E. S., Bowman, A. B., Nobis, W. P., & Harrison, F. E. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70821 · Cited by 2

HIV-1 Tat-driven Glutamate Dysregulation: Implications for Cognitive Impairment in HAND

Duffy, B. C., Nonnemacher, M. R., & Kortagere, S. (2026) · Current HIV/AIDS Reports · doi:10.1007/s11904-026-00789-w · Cited by 2

Astrocyte Glutamate Transporter EAAT2 in Alzheimer Dementia

Kurkinen, M. T. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_7 · Cited by 2

The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464

The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease

Tannenberg, R. K., Scott, H. L., Westphalen, R. I., & Dodd, P. R. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480591 · Cited by 37

Regional changes in [3H]d-aspartate and [3H]TCP binding sites in Alzheimer's disease brains

Simpson, M. D. C., Royston, M. C., Deakin, J. F. W., Cross, A. J., Mann, D. M. A., & Slater, P. (1988) · Brain Research · doi:10.1016/0006-8993(88)90587-2 · Cited by 74

Variant Forms of Neuronal Glutamate Transporter Sites in Alzheimer's Disease Cerebral Cortex

Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052193.x · Cited by 74

P3–199: The glutamate transporter, EAAT3 (EAAC1), is aberrantly expressed in hippocampus of individuals with Alzheimer's disease

Cook, D. G., Deurson, K., Leverenz, J. B., Bird, T. D., Montine, T. J., & Pow, D. V. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1467